Anaphylaxis

Chest

Volumn 153, Issue 2, 2018, Pages 528-543

  LoVerde, Daniel ^a   Iweala, Onyinye I ^b   Eginli, Ariana ^c   Krishnaswamy, Guha ^a,d,e  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c KAISER PERMANENTE MEDICAL CENTER   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e Kernersville Health Care Center   (United States)

Author keywords

allergy; anaphylaxis; angioedema; shock; urticaria

Indexed keywords

5 HYDROXYINDOLEACETIC ACID; ANTIHISTAMINIC AGENT; ANTIHYPERTENSIVE AGENT; ATRACURIUM BESILATE; BETA LACTAM; CEPHALOSPORIN; CORTICOSTEROID; DIPHENHYDRAMINE; DOPAMINE; EPINEPHRINE; GLUCAGON; GLUCOCORTICOID; HYDROCORTISONE; IMMUNOGLOBULIN E; METHYLPREDNISOLONE; MONOAMINE OXIDASE INHIBITOR; NORADRENALIN; PANCURONIUM; PREDNISONE; QUINOLONE; RETINOIC ACID; SALBUTAMOL; SULFONAMIDE; SUXAMETHONIUM; TRICYCLIC ANTIDEPRESSANT AGENT; VANCOMYCIN; VASOPRESSIN; ANTIINFLAMMATORY AGENT; BRONCHODILATING AGENT;

ABDOMINAL CRAMP; ABDOMINAL PAIN; AIRWAY OBSTRUCTION; ALLERGIC REACTION; ANAPHYLAXIS; ANGIONEUROTIC EDEMA; ANXIETY DISORDER; ASPHYXIA; BACTERIUM CULTURE; BONE MARROW BIOPSY; BRONCHOSPASM; CALCITONIN BLOOD LEVEL; CAPILLARY LEAK SYNDROME; CARCINOID; CARDIOGENIC SHOCK; CATECHOLAMINE BLOOD LEVEL; CELLULAR IMMUNITY; CEREBROVASCULAR ACCIDENT; CLINICAL FEATURE; CONFUSION; CONSULTATION; COUGHING; CYANOSIS; DEHYDRATION; DIAGNOSTIC TEST; DIARRHEA; DISEASE ASSOCIATION; DISEASE SEVERITY; DIZZINESS; DROWSINESS; DRUG HYPERSENSITIVITY; DYSPHONIA; ECHINOCOCCOSIS; ELECTROENCEPHALOGRAM; FACTITIOUS DISEASE; FAINTNESS; FECES INCONTINENCE; FLUID RESUSCITATION; FLUSHING; FOOD ALLERGY; FUNCTIONAL NEUROIMAGING; GENITAL PRURITUS; GLUCOSE BLOOD LEVEL; HEADACHE; HEART ARREST; HEART ARRHYTHMIA; HEART CATHETERIZATION; HEART DISEASE; HEART MUSCLE ISCHEMIA; HEART PALPITATION; HEMORRHAGIC SHOCK; HOARSENESS; HOSPITAL PATIENT; HOSPITALIZATION; HOT FLUSH; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; HYPOTENSION; HYPOVOLEMIA; HYPOVOLEMIC SHOCK; HYPOXEMIA; ICD-10; INTENSIVE CARE UNIT; ISCHEMIA; LARYNX EDEMA; MAST CELL LEUKEMIA; MASTOCYTOSIS; MENOPAUSE; MORTALITY RATE; NAUSEA; NONHUMAN; NOSE OBSTRUCTION; ONSET AGE; ORAL PRURITUS; OROPHARYNX; OUTPATIENT CARE; PAIN; PANIC; PATHOPHYSIOLOGY; PHEOCHROMOCYTOMA; POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME; PREVALENCE; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; PSYCHOSIS; RADIODIAGNOSIS; RESPIRATORY DISTRESS; RESPIRATORY FAILURE; RESTLESSNESS; REVIEW; RHINITIS; RISK FACTOR; SCROTAL SWELLING; SEIZURE; SEPTIC SHOCK; SKIN BIOPSY; SKIN PRURITUS; SOMATOFORM DISORDER; SPIROMETRY; STRIDOR; TACHYCARDIA; THYROID MEDULLARY CARCINOMA; TILT TABLE TEST; TIME OF DEATH; URINE INCONTINENCE; URTICARIA PIGMENTOSA; UTERUS BLEEDING; VASOCONSTRICTION; VASODILATATION; VISUAL DISORDER; VOCAL CORD DISORDER; VOMITING; WHEEZING; ARTIFICIAL VENTILATION; COMPLICATION; IMMUNOLOGY; LONG TERM CARE; PATHOLOGY; PROCEDURES;

ANAPHYLAXIS; ANTI-INFLAMMATORY AGENTS; BRONCHODILATOR AGENTS; EPINEPHRINE; GLUCOCORTICOIDS; HISTAMINE ANTAGONISTS; HUMANS; HYPOTENSION; IMMUNOGLOBULIN E; LIFE SUPPORT CARE; RESPIRATION, ARTIFICIAL;

EID: 85041907336     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1016/j.chest.2017.07.033     Document Type: Review

References (83)

1. Simons, F.E., Ardusso, L.R., Bilo, M.B., et al. International consensus on (ICON) anaphylaxis. World Allergy Organ J, 7(1), 2014, 9.
2. LoVerde, D., Files, D.C., Krishnaswamy, G., Angioedema. Crit Care Med 45:4 (2017), 725–735.
3. Campbell, R.L., Li, J.T., Nicklas, R.A., et al. Emergency department diagnosis and treatment of anaphylaxis: a practice parameter. Ann Allergy Asthma Immunol 113:6 (2014), 599–608.
4. Sclar, D.A., Lieberman, P.L., Anaphylaxis: underdiagnosed, underreported, and undertreated. Am J Med 127:1 Suppl (2014), S1–S5.
5. Ghably, J., Saleh, H., Vyas, H., et al. Paul Ehrlich's mastzellen: a historical perspective of relevant developments in mast cell biology. Methods Mol Biol 1220 (2015), 3–10.
6. Ring, J., Brockow, K., Behrendt, H., History and classification of anaphylaxis. Novartis Found Symp 257 (2004), 6–16.
7. Simons, F.E., Ebisawa, M., Sanchez-Borges, M., et al. 2015 update of the evidence base: World Allergy Organization anaphylaxis guidelines. World Allergy Organ J, 8(1), 2015, 32.
8. Lieberman, P., Nicklas, R.A., Randolph, C., et al. Anaphylaxis–a practice parameter update 2015. Ann Allergy Asthma Immunol 115:5 (2015), 341–384.
9. Ventura, M.T., Scichilone, N., Gelardi, M., et al. Management of allergic disease in the elderly: key considerations, recommendations and emerging therapies. Expert Rev Clin Immunol 11:11 (2015), 1219–1228.
10. Muraro, A., Roberts, G., Worm, M., et al. Anaphylaxis: guidelines from the European Academy of Allergy and Clinical Immunology. Allergy 69:8 (2014), 1026–1045.
11. Sampson, H.A., Munoz-Furlong, A., Campbell, R.L., et al. Second symposium on the definition and management of anaphylaxis: summary report–Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium. J Allergy Clin Immunol 117:2 (2006), 391–397.
12. Lee, S., Sadosty, A.T., Campbell, R.L., Update on biphasic anaphylaxis. Curr Opin Allergy Clin Immunol 16:4 (2016), 346–351.
13. Grunau, B.E., Li, J., Yi, T.W., et al. Incidence of clinically important biphasic reactions in emergency department patients with allergic reactions or anaphylaxis. Ann Emerg Med 63:6 (2014), 736–744.
14. Zisa, G., Riccobono, F., Calamari, A.M., et al. A case of protracted hypotension as unique symptom of a biphasic anaphylaxis to amoxicillin. Eur Ann Allergy Clin Immunol 41:2 (2009), 60–61.
15. Jerschow, E., Lin, R.Y., Scaperotti, M.M., et al. Fatal anaphylaxis in the United States, 1999-2010: temporal patterns and demographic associations. J Allergy Clin Immunol 134:6 (2014), 1318–1328.
16. Pumphrey, R.S., Fatal anaphylaxis in the UK, 1992-2001. Novartis Found Symp 257 (2004), 116–128.
17. Pumphrey, R.S., Lessons for management of anaphylaxis from a study of fatal reactions. Clin Exp Allergy 30:8 (2000), 1144–1150.
18. Altman, A.M., Camargo, C.A. Jr., Simons, F.E., et al. Anaphylaxis in America: a national physician survey. J Allergy Clin Immunol 135:3 (2015), 830–833.
19. Lieberman, P., Epidemiology of anaphylaxis. Curr Opin Allergy Clin Immunol 8:4 (2008), 316–320.
20. Lieberman, P., Camargo, C.A. Jr., Bohlke, K., et al. Epidemiology of anaphylaxis: findings of the American College of Allergy, Asthma and Immunology Epidemiology of Anaphylaxis Working Group. Ann Allergy Asthma Immunol 97:5 (2006), 596–602.
21. Wood, R.A., Camargo, C.A. Jr., Lieberman, P., et al. Anaphylaxis in America: the prevalence and characteristics of anaphylaxis in the United States. J Allergy Clin Immunol 133:2 (2014), 461–467.
22. Yang, M.S., Kim, J.Y., Kim, B.K., et al. True rise in anaphylaxis incidence: epidemiologic study based on a national health insurance database. Medicine (Baltimore), 96(5), 2017, e5750.
23. Jeppesen, A.N., Christiansen, C.F., Froslev, T., et al. Hospitalization rates and prognosis of patients with anaphylactic shock in Denmark from 1995 through 2012. J Allergy Clin Immunol 137:4 (2016), 1143–1147.
24. Ma, L., Danoff, T.M., Borish, L., Case fatality and population mortality associated with anaphylaxis in the United States. J Allergy Clin Immunol 133:4 (2014), 1075–1083.
25. Rohacek, M., Edenhofer, H., Bircher, A., et al. Biphasic anaphylactic reactions: occurrence and mortality. Allergy 69:6 (2014), 791–797.
26. Gibbison, B., Sheikh, A., McShane, P., et al. Anaphylaxis admissions to UK critical care units between 2005 and 2009. Anaesthesia 67:8 (2012), 833–839.
27. Krishnaswamy, G., Ajitawi, O., Chi, D.S., The human mast cell: an overview. Methods Mol Biol 315 (2006), 13–34.
28. Modena, B.D., Dazy, K., White, A.A., Emerging concepts: mast cell involvement in allergic diseases. Transl Res 174 (2016), 98–121.
29. Warkentin, T.E., Greinacher, A., Heparin-induced anaphylactic and anaphylactoid reactions: two distinct but overlapping syndromes. Expert Opin Drug Saf 8:2 (2009), 129–144.
30. Brown, S.G., Stone, S.F., Fatovich, D.M., et al. Anaphylaxis: clinical patterns, mediator release, and severity. J Allergy Clin Immunol 132:5 (2013), 1141–1149.
31. Vadas, P., Gold, M., Perelman, B., et al. Platelet-activating factor, PAF acetylhydrolase, and severe anaphylaxis. N Engl J Med 358:1 (2008), 28–35.
32. Brown, S.G., The pathophysiology of shock in anaphylaxis. Immunol Allergy Clin North Am 27:2 (2007), 165–175 v.
33. Gouel-Cheron, A., Harpan, A., Mertes, P.M., et al. Management of anaphylactic shock in the operating room. Presse Med 45:9 (2016), 774–783.
34. Kelley, J.L., Chi, D.S., Abou-Auda, W., et al. The molecular role of mast cells in atherosclerotic cardiovascular disease. Mol Med Today 6:8 (2000), 304–308.
35. Jang, D.H., Nelson, L.S., Hoffman, R.S., Methylene blue for distributive shock: a potential new use of an old antidote. J Med Toxicol 9:3 (2013), 242–249.
36. Lyons, J.J., Yu, X., Hughes, J.D., et al. Elevated basal serum tryptase identifies a multisystem disorder associated with increased TPSAB1 copy number. Nat Genet 48:12 (2016), 1564–1569.
37. Iweala, O.I., Burks, A.W., Food allergy: our evolving understanding of its pathogenesis, prevention, and treatment. Curr Allergy Asthma Rep, 16(5), 2016, 37.
38. Jarvinen, K.M., Food-induced anaphylaxis. Curr Opin Allergy Clin Immunol 11:3 (2011), 255–261.
39. Garvey, L.H., Old, new and hidden causes of perioperative hypersensitivity. Curr Pharm Des 22:45 (2016), 6814–6824.
40. Dona, I., Salas, M., Perkins, J.R., et al. Hypersensitivity Reactions to non-steroidal anti-inflammatory drugs. Curr Pharm Des 22:45 (2016), 6784–6802.
41. Bonamichi-Santos R, Castells M. Diagnoses and management of drug hypersensitivity and anaphylaxis in cancer and chronic inflammatory diseases: reactions to taxanes and monoclonal antibodies [published online ahead of print June 8, 2016]. Clin Rev Allergy Immunol. https://doi.org/10.1007/s12016-016-8556-5.
42. Williams, S.J., Gupta, S., Anaphylaxis to IVIG. Arch Immunol Ther Exp (Warsz) 65:1 (2017), 11–19.
43. Alvarez-de Lara, M.A., Martin-Malo, A., Hypersensitivity reactions to synthetic haemodialysis membranes an emerging issue?. Nefrologia 34:6 (2014), 698–702.
44. Wang, C., Wong, S., Graham, D.J., Risk of anaphylaxis with intravenous iron products. JAMA 315:20 (2016), 2232–2233.
45. Lee, S.Y., Ahn, K., Kim, J., et al. A multicenter retrospective case study of anaphylaxis triggers by age in Korean children. Allergy Asthma Immunol Res 8:6 (2016), 535–540.
46. Miller, C.W., Guha, B., Krishnaswamy, G., Exercise-induced anaphylaxis: a serious but preventable disorder. Phys Sportsmed 36:1 (2008), 87–94.
47. Schuch, A., Brockow, K., Mastocytosis and Anaphylaxis. Immunol Allergy Clin North Am 37:1 (2017), 153–164.
48. Pravettoni, V., Incorvaia, C., Diagnosis of exercise-induced anaphylaxis: current insights. J Asthma Allergy 9 (2016), 191–198.
49. Commins, S.P., Satinover, S.M., Hosen, J., et al. Delayed anaphylaxis, angioedema, or urticaria after consumption of red meat in patients with IgE antibodies specific for galactose-alpha-1,3-galactose. J Allergy Clin Immunol 123:2 (2009), 426–433.
50. Saleh, H., Embry, S., Nauli, A., et al. Anaphylactic reactions to oligosaccharides in red meat: a syndrome in evolution. Clin Mol Allergy, 10(1), 2012, 5.
51. Commins, S.P., Jerath, M.R., Cox, K., et al. Delayed anaphylaxis to alpha-gal, an oligosaccharide in mammalian meat. Allergol Int 65:1 (2016), 16–20.
52. Platts-Mills, T.A., Schuyler, A.J., Hoyt, A.E., et al. Delayed anaphylaxis involving IgE to galactose-alpha-1,3-galactose. Curr Allergy Asthma Rep, 15(4), 2015, 12.
53. Sabbah, A., Lauret, M.G., Chene, J., et al. [The pork-cat syndrome or crossed allergy between pork meat and cat epithelia (2)]. Allerg Immunol (Paris) 26:5 (1994), 173–180.
54. Hemmer, W., Klug, C., Swoboda, I., Update on the bird-egg syndrome and genuine poultry meat allergy. Allergo J Int 25 (2016), 68–75.
55. Hedlund, K.D., Coyne, D.P., Sanford, D.M., et al. The heparin recall of 2008. Perfusion 28:1 (2013), 61–65.
56. Kishimoto, T.K., Viswanathan, K., Ganguly, T., et al. Contaminated heparin associated with adverse clinical events and activation of the contact system. N Engl J Med 358:23 (2008), 2457–2467.
57. Fenny, N., Grammer, L.C., Idiopathic anaphylaxis. Immunol Allergy Clin North Am 35:2 (2015), 349–362.
58. Greenberger, P.A., Lieberman, P., Idiopathic anaphylaxis. J Allergy Clin Immunol. Pract 2:3 (2014), 243–250.
59. Kuhlen, J.L., Virkud, Y.V., Pathogenesis, newly recognized etiologies, and management of idiopathic anaphylaxis. Discov Med 19:103 (2015), 137–144.
60. Akin, C., Mast cell activation syndromes presenting as anaphylaxis. Immunol Allergy Clin North Am 35:2 (2015), 277–285.
61. Bonadonna, P., Bonifacio, M., Lombardo, C., et al. Hymenoptera allergy and mast cell activation syndromes. Curr Allergy Asthma Rep, 16(1), 2016, 5.
62. Snyder, J.L., Krishnaswamy, G., Autoimmune progesterone dermatitis and its manifestation as anaphylaxis: a case report and literature review. Ann Allergy Asthma Immunol 90:5 (2003), 469–477.
63. Bauer, C.S., Kampitak, T., Messieh, M.L., et al. Heterogeneity in presentation and treatment of catamenial anaphylaxis. Ann Allergy Asthma Immunol 111:2 (2013), 107–111.
64. Lee, J., Kim, S., Kim, M., et al. Anaphylaxis to husband's seminal plasma and treatment by local desensitization. Clin Mol Allergy, 6, 2008, 13.
65. Friedman, S.A., Bernstein, I.L., Enrione, M., et al. Successful long-term immunotherapy for human seminal plasma anaphylaxis. JAMA 251:20 (1984), 2684–2687.
66. Burks, A.W., Jones, S.M., Boyce, J.A., et al. NIAID-sponsored 2010 guidelines for managing food allergy: applications in the pediatric population. Pediatrics 128:5 (2011), 955–965.
67. Zogaj, D., Ibranji, A., Hoxha, M., Exercise-induced anaphylaxis: the role of cofactors. Mater Sociomed 26:6 (2014), 401–404.
68. Druey, K.M., Parikh, S.M., Idiopathic systemic capillary leak syndrome (Clarkson disease). J Allergy Clin Immunol 140:3 (2016), 663–670.
69. Feng, C., Teuber, S., Gershwin, M.E., Histamine (scombroid) fish poisoning: a comprehensive review. Clin Rev Allergy Immunol 50:1 (2016), 64–69.
70. Choy, A.C., Patterson, R., Patterson, D.R., et al. Undifferentiated somatoform idiopathic anaphylaxis: nonorganic symptoms mimicking idiopathic anaphylaxis. J Allergy Clin Immunol 96:6 Pt 1 (1995), 893–900.
71. Bahna, S.L., Oldham, J.L., Munchausen stridor-a strong false alarm of anaphylaxis. Allergy Asthma Immunol Res 6:6 (2014), 577–579.
72. Waterfield, T., Dyer, E., Wilson, K., et al. How to interpret mast cell tests. Arch Dis Child Educ Pract Ed 101:5 (2016), 246–251.
73. Vitte, J., Human mast cell tryptase in biology and medicine. Mol Immunol 63:1 (2015), 18–24.
74. Simons, F.E., Ardusso, L.R., Bilo, M.B., et al. World allergy organization guidelines for the assessment and management of anaphylaxis. World Allergy Organ J 4:2 (2011), 13–37.
75. Tsai, G., Kim, L., Nevis, I.F., et al. Auto-injector needle length may be inadequate to deliver epinephrine intramuscularly in women with confirmed food allergy. Allergy Asthma Clin Immunol, 10(1), 2014, 39.
76. Pumphrey, R.S., Fatal posture in anaphylactic shock. J Allergy Clin Immunol 112:2 (2003), 451–452.
77. Commins, S.P., Outpatient emergencies: anaphylaxis. Med Clin North Am 101:3 (2017), 521–536.
78. Brown, S.G., Cardiovascular aspects of anaphylaxis: implications for treatment and diagnosis. Curr Opin Allergy Clin Immunol 5:4 (2005), 359–364.
79. Zilberstein, J., McCurdy, M.T., Winters, M.E., Anaphylaxis. J Emerg Med 47:2 (2014), 182–187.
80. Thomas, M., Crawford, I., Best evidence topic report. Glucagon infusion in refractory anaphylactic shock in patients on beta-blockers. Emerg Med J 22:4 (2005), 272–273.
81. Sicherer, S.H., Simons, F.E.R., Section on Allergy and Immunology. Epinephrine for first-aid management of anaphylaxis. Pediatrics 139:3 (2017), e1–e9.
82. Zheng, F., Barthel, G., Collange, O., et al. Methylene blue and epinephrine: a synergetic association for anaphylactic shock treatment. Crit Care Med 41:1 (2013), 195–204.
83. Chan-Dominy, A.C., Anders, M., Millar, J., et al. Extracorporeal membrane modality conversions. Perfusion 0:4 (2015), 291–294.